INC Research

INC Research to close Old Lyme office

Wednesday, March 28, 2012 11:12 AM

INC Research, a CRO based in Raleigh, N.C., will be closing its Old Lyme office in Connecticut, laying off 66 employees in the process, according to the filing at the State of Connecticut Labor Department.

More... »

The CenterWatch Monthly, March 2012

Thursday, March 1, 2012 06:05 AM

Living in a post-M&A world of CROs

More... »

ClinStar names Koenig VP

Wednesday, December 21, 2011 03:04 PM

ClinStar has named Richard Koenig vice president, operations. In his new role, Richard will be responsible for project resourcing, project financial management and the development/maintenance of key project metrics

More... »

INC Research, SAS collaborate to improve clinical development

Wednesday, November 16, 2011 01:59 PM

INC Research and SAS are working together to improve clinical development risk management and achieve targeted product profiles through analytics. Collaborating with SAS, INC Research will offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency and flexibility. The ultimate goal is to improve a customer’s ability to manage risk, control investment and maximize ROI in clinical development.

More... »

CRO top executives in a game of ‘musical chairs’

Monday, November 7, 2011 08:02 AM

Five months after INC Research’s acquisition of Kendle International closed, executives from the now-combined CRO are landing jobs with competitors.  

More... »

Potthoff named president, CEO of Theorem Clinical Research

Wednesday, November 2, 2011 01:13 PM

John Potthoff has stepped down as chief operating officer of CRO INC Research to become president and CEO of Theorem Clinical Research, succeeding James Pusey, who now becomes Theorem’s executive chairman to the board of directors.

More... »

Carlyle Partners, Hellman & Friedman to acquire PPD for $3.9 billion, take the CRO private

Monday, October 10, 2011 08:02 AM

It’s official: Large equity investors Carlyle Partners and Hellman & Friedman Capital Partners are buying publicly traded PPD, taking the CRO private.

More... »

PPD names CEO, puts acquisition rumors in question

Monday, September 26, 2011 08:02 AM

PPD has named a new CEO, a move that strikes some in the industry as a little strange in the face of rumors that the publicly traded CRO is close to selling itself to a private equity firm.

More... »

INC Research forms partnership with Debiopharm Group

Wednesday, July 27, 2011 01:25 PM

INC Research, a therapeutically focused CRO, and Debiopharm Group, a Swiss-based global biopharmaceutical group, have formed a strategic partnership.

More... »

PPD shares rise on takeover rumors

Monday, July 18, 2011 01:51 PM

Shares of CRO Pharmaceutical Product Development (PPD) rose 16% to levels not touched in more than two-and-a-half years on Monday, a day after a Wall Street Journal report said the company was looking to sell itself, reported Reuters.

More... »